OPKO Health
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (35)
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
Started: 1/31/2023
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Started: 12/1/2016
A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency
Started: 6/1/2013
Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
Started: 12/7/2017
Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002
Started: 4/1/2013
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)
Started: 11/1/2009
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Started: 7/9/2018
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
Started: 6/1/2026
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Started: 2/1/2014
Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
Started: 11/2/2020
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Started: 2/21/2018
Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects
Started: 4/2/2018
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Started: 4/1/2014
Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Started: 2/1/2012
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Started: 9/1/2013
A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Started: 1/1/2013
ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease
Started: 6/1/2009
Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder
Started: 8/1/2012
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Started: 11/1/2012
MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)
Started: 8/1/2010
Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)
Started: 10/1/2010
Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)
Started: 1/1/2013
A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione
Started: 8/1/2008
Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants
Started: 12/1/2026
A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants
Started: 7/1/2014
A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B
Started: 5/1/2015
A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations
Started: 1/18/2019
A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male
Started: 1/22/2017
Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers
Started: 1/1/2015
A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects
Started: 2/1/2016
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
Started: 8/20/2018
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Started: 12/1/2014
Effects of TT301 on Cytokine Levels Post Endotoxin Challenge
Started: 5/1/2011
Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency
Started: 6/8/2018